JPM2023: Breakthroughs await, but so do roadblocks
pharmaphorum
JANUARY 13, 2023
At a Sunday pre-event, Eli Lilly and Company VP for Search and Evaluation for Neuro, Jenny Lair said that just a few years ago Lilly was having problems with people enrolled in trials who were diagnosed with Alzheimer’s, but didn’t actually have it. Ups and downs of government – IRA. Conclusion.
98 
Let's personalize your content